H. Haynes

发表

Treatment of carcinoma of the esophagus with 5‐fluorouracil and recombinant alfa‐2a‐interferon

S. Wadler, A. Rozenblit, P. Wiernik, 1993, Cancer.

Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus.

S. Wadler, J. Beitler, M. Camacho, 1999, American journal of clinical oncology.

Phase II trial of N-(phosphonacetyl)-l-aspartate (PALA), 5-fluorouracil and recombinant interferon-α-2b in patients with advanced gastric carcinoma

E. Thiel, S. Wadler, E. Kreuser, 1996 .

Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer

S. Wadler, J. Beitler, A. Rozenblit, 1995, Medical oncology.

All‐trans retinoic acid and interferon‐α‐2a in patients with metastatic or recurrent carcinoma of the uterine cervix

S. Hallam, C. Runowicz, S. Wadler, 1997 .

All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.

S. Hallam, C. Runowicz, S. Wadler, 1997, Cancer.

Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea.

S. Wadler, P. Wiernik, H. Haynes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors

S. Wadler, A. Kaubisch, A. Rozenblit, 2004, Cancer Chemotherapy and Pharmacology.

Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.

R. Ladner, S. Wadler, A. Murgo, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.

S. Wadler, E. Schwartz, D. Makower, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.

C. Runowicz, S. Wadler, J. Beitler, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck

S. Wadler, J. Beitler, T. Kotz, 2004, Investigational New Drugs.

Utility of embolization or chemoembolization as second‐line treatment in patients with advanced or recurrent colorectal carcinoma

S. Wadler, C. Bakal, P. Wiernik, 1994, Cancer.

Phase I clinical trial of parenteral hydroxyurea in combination with pelvic and para-aortic external radiation and brachytherapy for patients with advanced squamous cell cancer of the uterine cervix.

B. Vikram, C. Runowicz, S. Wadler, 2002, International journal of radiation oncology, biology, physics.

Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.

S. Wadler, H. Kaufman, A. Rozenblit, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II clinical trial with 5‐fluorouracil, recombinant interferon‐α‐2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus

S. Wadler, J. Beitler, P. Wiernik, 1996, Cancer.

Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma

C. Runowicz, S. Wadler, J. Beitler, 1995, The Journal of Laryngology & Otology.

Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)

D. Neuberg, A. Benson, S. Wadler, 1997, The cancer journal from Scientific American.

Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.

C. Runowicz, S. Wadler, E. Schwartz, 1999, The cancer journal from Scientific American.

The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.

C. Runowicz, S. Wadler, J. Beitler, 1996, Seminars in oncology.

Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-α-2a in patients with advanced malignancies

S. Wadler, A. Rozenblit, R. Schechner, 1995, Investigational New Drugs.